enhertuhcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /Content/ Disallow: /Files/ Sitemap: | ||
Meta Tags
| Title | ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Official HCP |
| Description | Extend HER2 Learn about ENHERTU® (fam-trastuzumab deruxtecan-nxki), an FDA-approved treatment option. See ISI, and full Prescribing Information, including Boxed WARNINGS, and Medication |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 40.118.104.64 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
enhertuhcp.com Valuation
|
US$22,540,032
Last updated: 2023-04-27 22:12:50
enhertuhcp.com has Semrush global rank of 469,578. enhertuhcp.com has an estimated worth of US$ 22,540,032, based on its estimated Ads revenue. enhertuhcp.com receives approximately 2,600,773 unique visitors each day. Its web server is located in United States, with IP address 40.118.104.64. According to SiteAdvisor, enhertuhcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$22,540,032 |
| Daily Ads Revenue | US$20,807 |
| Monthly Ads Revenue | US$624,186 |
| Yearly Ads Revenue | US$7,490,226 |
| Daily Unique Visitors | 173,385 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| enhertuhcp.com. | A | 7200 | IP: 40.118.104.64 |
| enhertuhcp.com. | NS | 7200 | NS Record: ns31.worldnic.com. |
| enhertuhcp.com. | NS | 7200 | NS Record: ns32.worldnic.com. |
| enhertuhcp.com. | TXT | 7200 | TXT Record: google-site-verification=teBLKU8cg5FLdUKbxu0rEOcAoi-Z1Mh4Wc6jFkiskIU |
HtmlToTextCheckTime:2023-04-27 22:12:50
| For US Healthcare Professionals. Important Safety Information Prescribing Information Medication Guide Patient Website ENHERTU 4U Patient Access to Treatment Nurse corner Resources for You Resources for Your Patients Financial Assistance Request a Contact Important Safety Information Prescribing Information Medication Guide HER2+ Metastatic Breast Cancer HER2-low Metastatic Breast Cancer HER2+ Advanced Gastric Cancer HER2 -Mutant Metastatic NSCLC Patient Website ENHERTU 4U Patient Access to Treatment Nurse corner Resources for You Resources for Your Patients Financial Assistance Request a Contact --> Extend HER2 EXPECTATIONS in multiple tumor types 1 Select Tumor Type: HER2-low Metastatic Breast Cancer HER2 -Mutant Metastatic NSCLC SEE UPDATED DATA HER2+ Metastatic Breast Cancer HER2+ Advanced Gastric Cancer Indications ENHERTU is a HER2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with: Unresectable or metastatic |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Type: text/html Content-length: 0 Connection: Close Location: https://www.enhertuhcp.com/ HTTP/1.1 200 OK Cache-Control: no-cache, no-store Pragma: no-cache Content-Length: 47981 Content-Type: text/html; charset=utf-8 Expires: -1 Server: Microsoft-IIS/10.0 X-Frame-Options: SAMEORIGIN Date: Thu, 21 Oct 2021 02:42:16 GMT |
enhertuhcp.com Whois Information
Domain Name: ENHERTUHCP.COM Registry Domain ID: 2411520722_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2019-07-10T20:07:22Z Creation Date: 2019-07-10T20:03:23Z Registry Expiry Date: 2022-07-10T20:03:23Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS31.WORLDNIC.COM Name Server: NS32.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-09T19:09:37Z <<< |